Daclizumab: A review of its use in the prevention of acute rejection in renal transplant patients (vol 58, pg 1029, 1999)

被引：0

|

作者：

Wiseman, LR

Faulds, D

机构：

来源：

DRUGS | 2000年 / 59卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：476 / 476

页数：1

相关论文

共 40 条

[31] Proteinuria Among Renal Transplant Patients and Its Relation to Hepatitis C Virus and Graft Outcome: A Single Center Experience (vol 8, pg 91, 2010)
Alaa, S.
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2010, 8 (03)
[32] Epoetin beta: A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure (vol 51, pg 314, 1996)
Dunn, CJ
Markham, A
DRUGS, 1996, 51 (05) : 894 - 894
[33] Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures (vol 9, pg 5719, 2015)
Mumoli, L.
Palleria, C.
Gasparini, S.
DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 6509 - 6509
[34] Controversies in Treating Asymptomatic Bacteriuria and Urinary Tract Infection: A Case Based Review of Antibiotic Use in Renal Transplant Patients and its Impact on the Development of Resistance
Vanga, Amaresh
Malhotra, Varun
Ripley, Kathryn
Khardori, Nancy
INDIAN JOURNAL OF PEDIATRICS, 2020, 87 (01): : 51 - 55
[35] Controversies in Treating Asymptomatic Bacteriuria and Urinary Tract Infection: A Case Based Review of Antibiotic Use in Renal Transplant Patients and its Impact on the Development of Resistance
Amaresh Vanga
Varun Malhotra
Kathryn Ripley
Nancy Khardori
The Indian Journal of Pediatrics, 2020, 87 : 51 - 55
[36] Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts (Vol 15, pg 20, 2021)
Kimmel, S. D.
Rosenmoss, S.
Bearnot, B.
JOURNAL OF ADDICTION MEDICINE, 2023, 17 (01) : 121 - 121
[37] Vedolizumab: A Review of Its Use in Adult Patients with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease (vol 29, pg 57, 2015)
Garnock-Jones, K. P.
BIODRUGS, 2015, 29 (01) : 73 - 73
[38] Aldesleukin (Recombinant interleukin-2). A review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma (vol 7, pg 285, 1997)
Jeal, W
Goa, KL
BIODRUGS, 1997, 8 (03) : 192 - 192
[39] Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series (vol 58, pg 510, 2020)
Nakamura, Hideta
Miyagi, Kazuya
Otsuki, Mariko
Higure, Yuuri
Nishiyama, Naoya
Kinjo, Takeshi
Nakamatsu, Masashi
Haranaga, Shusaku
Tateyama, Masao
Fujita, Jiro
RESPIRATORY INVESTIGATION, 2021, 59 (05) : 708 - 708
[40] The effect of CYP3A5 6986A>G and ABCB1 3435C>T on tacrolimus dose-adjusted trough levels and acute rejection rates in renal transplant patients: a systematic review and meta-analysis
Terrazzino, Salvatore
Quaglia, Marco
Stratta, Piero
Canonico, Pier L.
Genazzani, Armando A.
PHARMACOGENETICS AND GENOMICS, 2012, 22 (08): : 642 - 645

← 1 2 3 4 →